Cargando…

The New Role of SGLT2 Inhibitors in the Management of Heart Failure: Current Evidence and Future Perspective

The sodium-glucose transporter 2 inhibitors (SGLT2i) are a relatively new class of medication used in the management of type 2 diabetes. Recent clinical trials and research have demonstrated this class’s effectiveness in treating heart failure, since they reduce the risk of cardiovascular events, ho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muscoli, Saverio, Barillà, Francesco, Tajmir, Rojin, Meloni, Marco, Della Morte, David, Bellia, Alfonso, Di Daniele, Nicola, Lauro, Davide, Andreadi, Aikaterini
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9416279/ https://www.ncbi.nlm.nih.gov/pubmed/36015359 http://dx.doi.org/10.3390/pharmaceutics14081730

Ejemplares similares

Recent Pharmacological Options in Type 2 Diabetes and Synergic Mechanism in Cardiovascular Disease
por: Andreadi, Aikaterini, et al.
Publicado: (2023)

Insulin Resistance and Acne: The Role of Metformin as Alternative Therapy in Men
por: Andreadi, Aikaterini, et al.
Publicado: (2022)

Geographic and Ethnic Inequalities in Diabetes-Related Amputations
por: Bellia, Alfonso, et al.
Publicado: (2022)

Activation of Peripheral Blood Mononuclear Cells and Leptin Secretion: New Potential Role of Interleukin-2 and High Mobility Group Box (HMGB)1
por: Coppola, Andrea, et al.
Publicado: (2021)

Peripheral Blood Mononuclear Cells: A New Frontier in the Management of Patients with Diabetes and No-Option Critical Limb Ischaemia
por: Meloni, Marco, et al.
Publicado: (2023)

Prevalence and risk of new-onset diabetes mellitus after COVID-19: a systematic review and meta-analysis
por: Bellia, Chiara, et al.
Publicado: (2023)

Insulin and Exendin-4 Reduced Mutated Huntingtin Accumulation in Neuronal Cells
por: Rea, Silvia, et al.
Publicado: (2020)

Drug interactions of direct oral anticoagulants in elderly patients with cardiometabolic diseases
por: Bellia, Alfonso, et al.
Publicado: (2021)

Prevalence of Cardiovascular Risk Factors and Coronary Angiographic Findings in High-Risk Immigrant Communities in Italy
por: Muscoli, Saverio, et al.
Publicado: (2023)

Treatment of HFpEF beyond the SGLT2-Is: Does the Addition of GLP-1 RA Improve Cardiometabolic Risk and Outcomes in Diabetic Patients?
por: Belli, Martina, et al.
Publicado: (2022)

The Neuro-Ischaemic Charcot Foot: Prevalence, Characteristics and Severity of Peripheral Arterial Disease in Acute Charcot Neuro-Arthropathy
por: Meloni, Marco, et al.
Publicado: (2022)

The Impact of Vegan Diet in the Prevention and Treatment of Type 2 Diabetes: A Systematic Review
por: Pollakova, Daniela, et al.
Publicado: (2021)

Peroxiredoxin 6 Modulates Insulin Secretion and Beta Cell Death via a Mitochondrial Dynamic Network
por: Pacifici, Francesca, et al.
Publicado: (2022)

Peroxiredoxin 6 Is a Key Antioxidant Enzyme in Modulating the Link between Glycemic and Lipogenic Metabolism
por: Arriga, Roberto, et al.
Publicado: (2019)

Prdx6 Plays a Main Role in the Crosstalk between Aging and Metabolic Sarcopenia
por: Pacifici, Francesca, et al.
Publicado: (2020)

Glucose variability: a new risk factor for cardiovascular disease
por: Belli, Martina, et al.
Publicado: (2023)

Surgical treatment of post-menopausal ovarian hyperandrogenism improves glucometabolic profile alongside clinical hirsutism
por: De Taddeo, Sofia, et al.
Publicado: (2023)

Hypocalcemia is associated with adverse outcomes in patients hospitalized with COVID-19
por: Minasi, Alessandro, et al.
Publicado: (2022)

Polyphenols and Ischemic Stroke: Insight into One of the Best Strategies for Prevention and Treatment
por: Pacifici, Francesca, et al.
Publicado: (2021)

Current Options and Future Perspectives in the Treatment of Dyslipidemia
por: Muscoli, Saverio, et al.
Publicado: (2022)

Advances in Imaging for Tricuspid Transcatheter Edge-to-Edge Repair: Lessons Learned and Future Perspectives
por: Prandi, Francesca Romana, et al.
Publicado: (2023)

The Protective Effect of a Unique Mix of Polyphenols and Micronutrients against Neurodegeneration Induced by an In Vitro Model of Parkinson’s Disease
por: Pacifici, Francesca, et al.
Publicado: (2022)

Age-Dependent Levels of Protein Kinase Cs in Brain: Reduction of Endogenous Mechanisms of Neuroprotection
por: Pastore, Donatella, et al.
Publicado: (2019)

Nephroprotection by SGLT2 Inhibition: Back to the Future?
por: De Nicola, Luca, et al.
Publicado: (2020)

The Potential of SGLT-2 Inhibitors in the Treatment of Polycystic Ovary Syndrome: The Current Status and Future Perspectives
por: Rakic, Dejana, et al.
Publicado: (2023)

SGLT-2 Inhibitors in Heart Failure: A Review of Current Evidence
por: Talha, Khawaja M., et al.
Publicado: (2023)

Proposed Tandem Effect of Physical Activity and Sirtuin 1 and 3 Activation in Regulating Glucose Homeostasis
por: Pacifici, Francesca, et al.
Publicado: (2019)

Losing Weight after Menopause with Minimal Aerobic Training and Mediterranean Diet
por: Lombardo, Mauro, et al.
Publicado: (2020)

Glucagon Like Peptide 1 and MicroRNA in Metabolic Diseases: Focusing on GLP1 Action on miRNAs
por: Capuani, Barbara, et al.
Publicado: (2018)

Severe hypoglycemia in patients with known diabetes requiring emergency department care: A report from an Italian multicenter study
por: Mantovani, Alessandro, et al.
Publicado: (2016)

Sotagliflozin, the first dual SGLT inhibitor: current outlook and perspectives
por: Cefalo, Chiara Maria Assunta, et al.
Publicado: (2019)

SGLT‐2 Inhibitors in Heart Failure: Current Management, Unmet Needs, and Therapeutic Prospects
por: Lam, Carolyn S. P., et al.
Publicado: (2019)

Current Utilization Trends of SGLT-2 Inhibitors in Type 2 Diabetics With Heart Failure
por: Dhillon, Puneet, et al.
Publicado: (2021)

Tyrosol May Prevent Obesity by Inhibiting Adipogenesis in 3T3-L1 Preadipocytes
por: Pacifici, Francesca, et al.
Publicado: (2020)

Are SGLT-2 Inhibitors the Future of Heart Failure Treatment? The EMPEROR-Preserved and EMPEROR-Reduced Trials
por: Williams, David M., et al.
Publicado: (2020)

SGLT1 and SGLT1 Inhibitors: A Role to Be Assessed in the Current Clinical Practice
por: Spatola, Leonardo, et al.
Publicado: (2017)

Gut Microbiota Composition and Cardiovascular Disease: A Potential New Therapeutic Target?
por: Belli, Martina, et al.
Publicado: (2023)

Ideal P2Y12 Inhibitor in Acute Coronary Syndrome: A Review and Current Status
por: Pradhan, Akshyaya, et al.
Publicado: (2022)

Foot Revascularization Avoids Major Amputation in Persons with Diabetes and Ischaemic Foot Ulcers
por: Meloni, Marco, et al.
Publicado: (2021)

Does SGLT1 inhibition add to the benefits of SGLT2 inhibition in the prevention and treatment of heart failure?
por: Pitt, Bertram, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1v0r6ojr4he043sg9fpmj8ashh